Boostrix Polio

Boostrix Polio Contraindications

Manufacturer:

GlaxoSmithKline

Distributor:

Zuellig
Full Prescribing Info
Contraindications
Hypersensitivity to the active substances or to any of the excipients listed in Description or to neomycin or polymyxin.
Hypersensitivity after previous administration of diphtheria, tetanus, pertussis or poliomyelitis vaccines.
Boostrix Polio is contraindicated if the subject has experienced an encephalopathy of unknown aetiology, occurring within 7 days following previous vaccination with pertussis-containing vaccine. In these circumstances, pertussis vaccination should be discontinued and the vaccination course should be continued with diphtheria, tetanus and poliomyelitis vaccines.
Boostrix Polio should not be administered to subjects who have experienced transient thrombocytopenia or neurological complications (for convulsions or hypotonic-hyporesponsive episodes, see Precautions) following an earlier immunisation against diphtheria and/or tetanus.
As with other vaccines, administration of Boostrix Polio should be postponed in subjects suffering from acute severe febrile illness. The presence of a minor infection is not a contraindication.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Already a member? Sign in
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Already a member? Sign in